Versant Capital Management’s Orthofix Medical OFIX Stock Holding History

Versant Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12K	Sell	1,317 -521	-28%	-$5.75K	﹤0.01%	2163
2026 Q1	$21.1K	Buy	1,838 +1,420	+340%	+$18.7K	﹤0.01%	1795
2025 Q4	$6.34K	Buy	418 +176	+73%	+$2.69K	﹤0.01%	2166
2025 Q3	$3.54K	Hold	242	–	–	﹤0.01%	2315
2025 Q2	$2.7K	Buy	242 +177	+272%	+$2.19K	﹤0.01%	2327
2025 Q1	$1.06K	Hold	65	–	–	﹤0.01%	2347
2024 Q4	$1.14K	Buy	+65	New	+$1.13K	﹤0.01%	2166
2024 Q2	–	Sell	-679	Closed	-$9.86K	–	1985
2024 Q1	$9.86K	Sell	679 -22	-3%	-$304	﹤0.01%	788
2023 Q4	$9.45K	Buy	+701	New	+$8.24K	﹤0.01%	768
2023 Q3	–	Sell	-204	Closed	-$3.68K	–	2018
2023 Q2	$3.68K	Buy	+204	New	+$3.81K	﹤0.01%	1150
2022 Q4	–	Sell	-937	Closed	-$18K	–	1680
2022 Q3	$18K	Buy	937 +582	+164%	+$13.1K	0.01%	451
2022 Q2	$8K	Sell	355 -26	-7%	-$745	﹤0.01%	718
2022 Q1	$12K	Buy	381 +20	+6%	+$643	﹤0.01%	639
2021 Q4	$11K	Sell	361 -30	-8%	-$1K	﹤0.01%	693
2021 Q3	$15K	Buy	391 +14	+4%	+$557	0.01%	580
2021 Q2	$15K	Sell	377 -4	-1%	-$169	0.01%	585
2021 Q1	$17K	Hold	381	–	–	0.01%	611
2020 Q4	$16K	Hold	381	–	–	0.01%	581
2020 Q3	$11K	Buy	381 +164	+76%	+$5.09K	﹤0.01%	629
2020 Q2	$6K	Buy	217 +181	+503%	+$6.01K	﹤0.01%	805
2020 Q1	$1K	Sell	36 -74	-67%	-$2.86K	﹤0.01%	1177
2019 Q4	$5K	Sell	110 -4	-4%	-$188	﹤0.01%	942
2019 Q3	$6K	Hold	114	–	–	﹤0.01%	901
2019 Q2	$6K	Sell	114 -3	-3%	-$160	﹤0.01%	916
2019 Q1	$6K	Buy	117 +7	+6%	+$393	﹤0.01%	1060
2018 Q4	$5K	Hold	110	–	–	﹤0.01%	1032
2018 Q3	$6K	Hold	110	–	–	﹤0.01%	1046
2018 Q2	$6K	Hold	110	–	–	﹤0.01%	1037
2018 Q1	$6K	Hold	110	–	–	﹤0.01%	1032
2017 Q4	$6K	Hold	110	–	–	﹤0.01%	1073
2017 Q3	$5K	Buy	110 +100	+1,000%	+$4.71K	﹤0.01%	1062
2017 Q2	$0	Hold	10	–	–	﹤0.01%	1511
2017 Q1	$0	Hold	10	–	–	﹤0.01%	1507
2016 Q4	$0	Hold	10	–	–	﹤0.01%	1484
2016 Q3	$0	Buy	+10	New	+$446	﹤0.01%	1453

Other funds holding OFIX

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

KMC

Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

TSMHT

Thurston Springer Miller Herd & Titak Indianapolis, Indiana $275M AUM 30.64% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

APW

Aventura Private Wealth Aventura, Florida $326M AUM 34.36% 1-Year Est. Return

Versant Capital Management's OFIX Position: Q2 2026 in Review

Versant Capital Management reduced its Orthofix Medical (OFIX) stake by 28% in Q2 2026, selling an estimated $5.75K and leaving 1,317 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2163.

Versant Capital Management first reported a position in OFIX in Q3 2016 and has held it in 35 quarters since. The position peaked at $21.1K in Q1 2026. 12 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

Versant Capital Management held 1,317 shares of Orthofix Medical worth $12K as of Q2 2026.
Versant Capital Management sold 521 Orthofix Medical shares in Q2 2026, an estimated $5.75K.
Orthofix Medical made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2163 holding.
Versant Capital Management first reported a position in Orthofix Medical in Q3 2016 and has held it in 35 quarters since.
Versant Capital Management's Orthofix Medical position peaked at $21.1K in Q1 2026.
12 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.